Technical Analysis for BAX - Baxter International Inc.

Grade Last Price % Change Price Change
grade A 70.63 2.18% 1.51
BAX closed up 2.18 percent on Friday, January 18, 2019, on 79 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Jan 31

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Up Up
See historical BAX trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 200 DMA Bullish 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Multiple of Ten Bullish Other 0.00%
Jan 18 Above Upper BB Strength 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 Pocket Pivot Bullish Swing Setup 2.18%
Jan 17 Overbought Stochastic Strength 2.18%

Older signals for BAX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.
Is BAX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 78.38
52 Week Low 61.05
Average Volume 4,327,166
200-Day Moving Average 70.4807
50-Day Moving Average 65.6822
20-Day Moving Average 65.955
10-Day Moving Average 67.507
Average True Range 1.465
ADX 16.13
+DI 36.3414
-DI 16.5166
Chandelier Exit (Long, 3 ATRs ) 66.42499999999999
Chandelier Exit (Short, 3 ATRs ) 65.795
Upper Bollinger Band 70.2214
Lower Bollinger Band 61.6886
Percent B (%b) 1.05
BandWidth 12.937306
MACD Line 0.8896
MACD Signal Line 0.367
MACD Histogram 0.5227
Fundamentals Value
Market Cap 38.49 Billion
Num Shares 545 Million
EPS 1.65
Price-to-Earnings (P/E) Ratio 42.81
Price-to-Sales 3.44
Price-to-Book 3.85
PEG Ratio 2.01
Dividend 0.64
Dividend Yield 0.91%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 73.18
Resistance 3 (R3) 72.96 71.89 72.76
Resistance 2 (R2) 71.89 71.24 72.00 72.61
Resistance 1 (R1) 71.26 70.84 71.58 71.48 72.47
Pivot Point 70.19 70.19 70.35 70.30 70.19
Support 1 (S1) 69.56 69.54 69.88 69.78 68.79
Support 2 (S2) 68.49 69.14 68.60 68.65
Support 3 (S3) 67.86 68.49 68.51
Support 4 (S4) 68.08